SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global,” “SGMD,” or the “Company”) (TSXV:SGMD), announces the issuance to Dennis Nelson, its Chief Financial Officer, of options to acquire an aggregate of 200,000 Common Shares of the Company at an exercise price of $0.69 per share (the “Options”). The Options have been issued under the Company’s 2021 Amended and Restated Stock Option Plan, and they are subject to the terms thereof and are exercisable as follows: Options to acquire 66,666 Common Shares are exercisable, at any time and from time to time, commencing on each of the first, second, and third anniversary of the date of issuance through August 29, 2027. The Options and underlying Common Shares will be subject to a TSX Venture Exchange four month hold period.
For more information please contact:
Luke Faulstick
Chief Executive Officer
Tel: 1 (800) 760-6826
Email: Info@Salonaglobal.com
Additional Information
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Unless otherwise specified, all dollar amounts in this press release are expressed in Canadian dollars.
